Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors (Cardiac-CV)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01740739|
Recruitment Status : Suspended (Evaluating cohort for value)
First Posted : December 4, 2012
Last Update Posted : June 14, 2013
|Condition or disease|
|Cardiovascular Diseases Coronary Artery Disease|
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors (Cardiac-CV)|
|Study Start Date :||November 2012|
|Estimated Primary Completion Date :||June 2013|
|Estimated Study Completion Date :||June 2013|
Patients, as part of their standard of care, who are recommended for and who complete a test resulting in a Coronary Calcium Score, lipid test, hs-CRP and MPO result.
- Association of ClearView scan with cardiovascular risk indicators [ Time Frame: Single Study Vist, no follow-up. ]Statistical agreement will be assessed between the ClearView Response result and the results of the Corinary Calcium Score, Inflammatory biomarkers, lipid panel results and cardiovascular risk indicators as reported by the medical exam, on a per-subject basis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01740739
|United States, California|
|Mission Internal Medical Group|
|Mission Viejo, California, United States, 92691|
|Principal Investigator:||Michael Miyamoto, MD||Mission Internal Medical Group|